Trials / Completed
CompletedNCT00499642
Study Evaluating the Effect of Lecozotan SR on the QTc Interval
A Single-Dose, Double-Blind, Crossover, Placebo- and Moxifloxacin (Open-Label)-Controlled Study of the Effects of Lecozotan SR on Cardiac Repolarization in Healthy Adult Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
This is a randomized, double-blind, placebo- and moxifloxacin (open-label)-controlled, 4-period crossover study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lecozotan SR | |
| DRUG | Moxifloxacin |
Timeline
- Start date
- 2007-06-01
- Completion
- 2007-08-01
- First posted
- 2007-07-11
- Last updated
- 2007-12-28
Locations
2 sites across 1 country: France
Source: ClinicalTrials.gov record NCT00499642. Inclusion in this directory is not an endorsement.